Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis
Not Applicable
Terminated
- Conditions
- Moderate to Severe Atopic Dermatitis
- Interventions
- Other: Dilute bleach bathsOther: Water
- Registration Number
- NCT01286220
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Brief Summary
The purpose of this study is to determine if twice weekly 10 minute dilute bleach baths decreases disease severity in patients with moderate to severe atopic dermatitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
- 2-17 years of age at time of consent. A parent or legal guardian will be required to consent and authorize their enrollment in the study.
- Male or female of any ethnic background.
- English or Spanish speaking.
- A clinical diagnosis of atopic dermatitis for at least 6 months prior to enrollment.
- Must have moderate to severe atopic dermatitis as rated by the EASI score.
- Able to adhere to study visit schedule and other protocol requirements.
- Patients and/or family members must agree to not use any other prescription or over the counter medications other than the ones prescribed by the study protocol.
Exclusion Criteria
- Clinical evidence of bacterial or viral superinfection on first visit.
- Have received phototherapy within 2 months prior to enrollment.
- Have received any systemic medication for atopic dermatitis or any that may affect evaluation of atopic dermatitis within 2 months prior to enrollment.
- Have a known hypersensitivity response, including anaphylaxis, to any of the topicals used for treatment (i.e. topical steroids, bleach)
- Participation in another clinical trial using an investigational agent or procedure.
- Pregnant or planning pregnancy or surgery during the participation in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Dilute bleach baths Dilute bleach baths Patients in the intervention group will be instructed to bathe in a dilute bleach bath twice weekly for 10 minutes. Water Water Patients in the placebo group will be instructed to bathe in plain water twice weekly for 10 minutes.
- Primary Outcome Measures
Name Time Method Eczema Area and Severity Index Score (EASI) Change in EASI score from baseline at 1 month and 3 month follow ups EASI score is recorded at baseline, 1 month and 3 month follow ups.
- Secondary Outcome Measures
Name Time Method Investigator's Global Assessment (IGA) Change in IGA score from baseline at 1 month and 3month follow ups IGA scores are recorded at baseline, 1 month and 3 month follow ups.
Trial Locations
- Locations (1)
Children's Medical Center of Dallas
🇺🇸Dallas, Texas, United States